(Q43001185)

12 November 2017

C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2b (English)

1 reference

12 November 2017

L Bíró

1

1 reference

12 November 2017

L Varga

2

1 reference

12 November 2017

A Pár

3

1 reference

12 November 2017

E Nemesánszky

4

1 reference

12 November 2017

L Telegdy

5

1 reference

12 November 2017

E Ibrányi

6

1 reference

12 November 2017

K Dávid

7

1 reference

12 November 2017

G Horváth

8

1 reference

12 November 2017

L Szentgyörgyi

9

1 reference

12 November 2017

I Nagy

10

1 reference

12 November 2017

L Dalmi

11

1 reference

12 November 2017

M Abonyi

12

1 reference

12 November 2017

G Füst

13

1 reference

12 November 2017

M Horányi

14

1 reference

12 November 2017

A Csepregi

15

1 reference

12 November 2017

1 October 2000

1 reference

Scandinavian Journal of Gastroenterology

12 November 2017

1 reference

12 November 2017

35

1 reference

12 November 2017

10

1 reference

12 November 2017

1092-1096

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

12 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Fluid phase generation of terminal complement complex as a novel index of bioincompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655200451234

21 January 2018

Identifiers

DOI

10.1080/003655200451234

1 reference

release_twvvnpf5hzekbguiuz2jrdqyqm

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/twvvnpf5hzekbguiuz2jrdqyqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference